Email ID
Password
Scrip   
Teva's earnings treble in first quarter
06 May 2009
Sita Shah

Teva Pharmaceutical Industries's first-quarter GAAP net income trebled to $451 million, boosted by the acquisition of Barr Pharmaceuticals and strong sales from its therapeutic portfolio.

The company's net sales grew by 22% to $3.15 billion. The strength of the US dollar adversely affected...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36